Sessions in the programme
Friday, 9 October
-
Speakers Hall E
OP-011: Real-World Effectiveness of CDK4/6 Inhibitors Plus Endocrine Therapy in ER-Low (1–10%) HR+/HER2- Metastatic Breast Cancer: A Single-Center Cohort Study
Session: Oral Papers Session I — Medical Oncology & Radiation Oncology